Effect of Body Mass Index in Patients Undergoing Resection for Gastric Cancer: A Single Center US Experience

Journal of Gastrointestinal Surgery

Volumn 18, Issue 3, 2014, Pages 505-511

  Wong, Joyce ^a   Rahman, Shams ^a   Saeed, Nadia ^a   Lin, Hui Yi ^a   Almhanna, Khaldoun ^a   Shridhar, Ravi ^a   Hoffe, Sarah ^a   Meredith, Kenneth L ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Body mass index; Gastric cancer; Resection

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD VESSEL; BODY MASS; DISEASE FREE SURVIVAL; FEMALE; GASTRECTOMY; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH VESSEL; MALE; METASTASIS; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MORTALITY; OPERATION DURATION; PATHOLOGY; PERIPHERAL NERVE; RETROSPECTIVE STUDY; STOMACH TUMOR; SURVIVAL RATE; TUMOR INVASION; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSELS; BODY MASS INDEX; DISEASE-FREE SURVIVAL; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM, RESIDUAL; OPERATIVE TIME; PERIPHERAL NERVES; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 84894420787     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-014-2455-y     Document Type: Article

References (34)

1. nd Edition. Atlanta: American Cancer Society; 2011.
2. American Cancer Society. Cancer facts & figures 2012. Atlanta: American Cancer Society; 2012.
3. Strong VE, Song KY, Park CH, et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Annals of Surgery, 2010; 251(4): 640-6.
4. Bonenkamp JJ, van de Velde CJ, Kampschoer GH, et al. Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients. World Journal of Surgery, 1993; 17(3): 410-4.
5. Wu CW, Hsiung CA, Lo SS, et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. The Lancet Oncology, 2006; 7(4): 309-315.
6. Hartgrink HH, van de Velde CJH, Putter J, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. Journal of Clinical Oncology, 2004; 22: 2069-2077.
7. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized survival trial. British Journal of Cancer, 1999; 79: 1522-1530.
8. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9. 1 million participants. Lancet, 2011; 377(9765): 557-67.
9. Calle EE, Rodriguez C, Walker-Thurmond K, and Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. NEJM, 2003; 348: 1625-1638.
10. Abnet CC, Freedman ND, Hollenbeck AR, et al. A prospective study of BMI and risk of esophageal and gastric adenocarcinoma. European Journal of Cancer, 2008; 44(3): 465-471.
11. Cho Y, Lee DH, Oh HS, et al. Higher prevalence of obesity in gastric cardia adenocarcinoma compared to gastric non-cardia adenocarcinoma. Digestive Diseases and Sciences, 2012; 57(10): 2687-92.
12. O'Doherty MG, Freedman ND, Hollenbeck AR, et al. A prospective cohort study of obesity and risk of esophageal and gastric adenocarcinoma in the NIH-AARP Diet and health study. Gut, 2012; 61(9): 1261-8.
13. Kant P, Hull MA. Excess body weight and obesity-the link with gastrointestinal and hepatobiliary cancer. Nature Reviews. Gastroenterology and Hepatology, 2011; 8(4): 224-38.
14. Kulig J, Sierzega M, Kolodziejczyk P, et al. Implications of overweight in gastric cancer: a multicenter study in a Western patient population. European Journal of Surgical Oncology, 2010; 36(10): 969-76.
15. Bickenbach KA, Denton B, Gonen M, et al. Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Annals of Surgical Oncology, 2013; 20(3): 780-7.
16. Park SM, Lim MK, Shin SA, Yun YH. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. Journal of Clinical Oncology, 2006; 24(31): 5017-24.
17. Malik VS, Willett WC, Hu FB. Global obesity: trends, risk factors and policy implications. Nature Reviews Endocrinology, 2012; 9(1): 13-27.
18. Haakinson DJ, Leeds SG, Dueck AC, et al. The impact of obesity on breast cancer: a retrospective review. Annals of Surgical Oncology, 2012; 19(9): 3012-8.
19. Lu Y, Ma H, Malone KE, et al. Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. Journal of Clinical Oncology, 2011; 29(25): 3358-65.
20. Aune D, Greenwood DC, Chan DS, et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Annals of Oncology, 2012; 23(4): 843-52.
21. Gribovskaja-Rupp I, Kosinski L, Ludwig KA. Obesity and colorectal cancer. Clinics in Colon and Rectal Surgery, 2011; 24(4): 229-43.
22. Tokunaga M, Hiki N, Fukunaga T, et al. Annals of Surgical Oncology, 2009; 16(12): 3245-51.
23. Ojima T, Iwahashi M, Nakamori M, et al. Influence of overweight on patients with gastric cancer after undergoing curative gastrecomy. An analysis of 689 consecutive cases managed by a single center. Archives of Surgery, 2009; 144(4): 351-358.
24. Yasunaga H, Horiguchi H, Matsuda S, et al. Body mass index and outcomes following gastrointestinal cancer surgery in Japan. British Journal of Surgery, 2013; 100(10): 1335-43.
25. Lin YS, Huang KH, Lan YT, et al. Impact of body mass index on postoperative outcome of advanced gastric cancer after curative surgery. Journal of Gastrointestinal Surgery, 2013; 17(8): 1382-91.
26. Yamada H, Kojima K, Inokuchi M, et al. Effect of obesity on technical feasibility and postoperative outcomes of laparoscopy-assisted distal gastrectomy-comparison with open distal gastrectomy. Journal of Gastrointestinal Surgery, 2008; 12(6): 997-1004.
27. Son T, Hyung WJ, Lee JH, et al. Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer. Cancer, 2012; 118 (19): 4687-93.
28. Han DS, Suh YS, Kong SH, et al. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. Journal of Clinical Oncology, 2012; 30(31): 3834-40.
29. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Gastric Cancer. Version 2. 2012. NCCN. org.
30. Bilici A, Seker M, Ustaalioglu BB, et al. Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection. Annals of Surgical Oncology, 2010; 17(8): 2037-44.
31. Wang SY, Yeh CN, Lee HL, et al. Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy. Annals of Surgical Oncology, 2009; 16(10): 2738-43.
32. Bray GA. Medical consequences of obesity. Journal of Clinical Endocrinology & Metabolism, 2004; 89(6): 2583-2589.
33. Matthews CE, Sui X, LaMonte MJ, et al. Metabolic syndrome and risk of death from cancers of the digestive system. Metabolism, 2010; 59(8): 1231-1239.
34. Lindkvist B, Almquist M, Bjorge T, et al. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can). Cancer Causes Control, 2013; 24(1): 107-16.